ChartMill assigns a Buy % Consensus number of 83% to GALT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-02 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-27 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-05-17 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-16 | HC Wainwright & Co. | Maintains | Buy |
7 analysts have analysed GALT and the average price target is 6.12 USD. This implies a price increase of 14.39% is expected in the next year compared to the current price of 5.35.
The consensus rating for GALECTIN THERAPEUTICS INC (GALT) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering GALECTIN THERAPEUTICS INC (GALT) is 7.